Literature DB >> 21913792

The evaluation of colloidal gold immunochromatographic assay (GICA) for rapid diagnosis of influenza A disease.

Xuehui Li1, Hangwei Chen, Juan Wei, Nan Lv, Lanhua You.   

Abstract

BACKGROUND: A low cost colloidal gold immunochromatographic assay (GICA) for rapid detection of influenza A virus was developed. The assay was evaluated in this study.
METHODS: Six hundred and twenty-six patients were enrolled. All patients contributed two pharyngeal swabs, one used for colloidal gold immunochromatographic rapid assay for influenza A virus immediately after the collection of specimen and one used for real-time reverse transcriptase polymerase chain reaction (RT-PCR) test or virus culture at the Centers for Disease Control and Prevention (CDC) influenza network laboratory. RESULT: In reference to viral culture, GICA influenza A test demonstrated a sensitivity of 64%, a specificity of 95% and an overall accuracy of 93%. Consistency between the GICA test and virus culture assay is moderate, with Kappa being 0.46. In reference to RT-PCR, GICA test demonstrated considerable high sensitivity (74%) and specificity (86%), with Kappa value being 0.61 and overall accuracy of 81%. There was no significant difference between GICA test and virus culture/RT-PCR on the detected positive rates of influenza A cases.
CONCLUSIONS: GICA is a reliable, rapid, convenient and inexpensive test for the screening and diagnosis of influenza A disease. Given its lower cost than other rapid tests, the GICA test has the great potential in the management of influenza A disease in resource-poor countries.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21913792     DOI: 10.1515/CCLM.2011.235

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  5 in total

1.  Clinical evaluation of a rapid colloidal gold immunochromatography assay for SARS-Cov-2 IgM/IgG.

Authors:  Bo Shen; Yufen Zheng; Xiaoyan Zhang; Weituo Zhang; Donglian Wang; Jie Jin; Rong Lin; Ying Zhang; Guangjun Zhu; Hongguo Zhu; Jun Li; Jiaqin Xu; Xianhong Ding; Shiyong Chen; Ruyue Lu; Zebao He; Haihong Zhao; Lingjun Ying; Chao Zhang; Dongqing Lv; Baofu Chen; Jiya Chen; Jiansheng Zhu; Bingjie Hu; Chenliang Hong; Xiangyu Xu; Jiaxi Chen; Chong Liu; Kai Zhou; Jing Li; Guoling Zhao; Weixiang Shen; Chunfeng Chen; Chunyan Shao; Xiaoying Shen; Jingjing Song; Zhipeng Wang; Ying Meng; Chao Wang; Junsong Han; Aojun Chen; Daru Lu; Biyun Qian; Haixiao Chen; Hengjun Gao
Journal:  Am J Transl Res       Date:  2020-04-15       Impact factor: 4.060

2.  Evaluation of a rapid detection influenza virus a antigens kit using paired serum antibody test.

Authors:  Hangwei Chen; Huimin Wang; Xuehui Li; Lanhua You; Juan Wei; Weixian Shi
Journal:  Yonsei Med J       Date:  2013-03-01       Impact factor: 2.759

3.  Comparison of a new gold immunochromatographic assay for the rapid diagnosis of the novel influenza A (H7N9) virus with cell culture and a real-time reverse-transcription PCR assay.

Authors:  Changzhong Jin; Nanping Wu; Xiaorong Peng; Hangping Yao; Xiangyun Lu; Yu Chen; Haibo Wu; Tiansheng Xie; Linfang Cheng; Fumin Liu; Keren Kang; Shixing Tang; Lanjuan Li
Journal:  Biomed Res Int       Date:  2014-04-14       Impact factor: 3.411

4.  A method for measuring the experimental resolution of laboratory assays (clinical biochemical, blood count, immunological, and qPCR) to evaluate analytical performance.

Authors:  Chenxi Sun; Dongxia Wang; Henggui Xu; Guang Yang; Xiaomei Yan; Hui Liu
Journal:  J Clin Lab Anal       Date:  2021-11-01       Impact factor: 2.352

Review 5.  Coronavirus Disease 2019 (COVID-19) Diagnostic Tools: A Focus on Detection Technologies and Limitations.

Authors:  Ahmad Qasem; Ameera M Shaw; Erij Elkamel; Saleh A Naser
Journal:  Curr Issues Mol Biol       Date:  2021-07-20       Impact factor: 2.976

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.